TY - JOUR AU - Rosenberg, B. AU - Camp, L. AU - Grimley, E. B. AU - Thomson, A. J. PY - 1967 DA - 1967// TI - The inhibition of growth or cell division in Escherichia coli by different ionic species of platinum (IV) complexes JO - J Biol Chem VL - 242 ID - Rosenberg1967 ER - TY - JOUR AU - Rosenberg, B. AU - Vancamp, L. AU - Krigas, T. PY - 1965 DA - 1965// TI - Inhibition of cell division in Escherichia Coli by electrolysis products from a platinum electrode JO - Nature VL - 205 UR - https://doi.org/10.1038/205698a0 DO - 10.1038/205698a0 ID - Rosenberg1965 ER - TY - JOUR AU - Rius, M. AU - Lyko, F. PY - 2012 DA - 2012// TI - Epigenetic cancer therapy: rationales, targets and drugs JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2011.601 DO - 10.1038/onc.2011.601 ID - Rius2012 ER - TY - JOUR AU - Sharma, P. AU - Hu-Lieskovan, S. AU - Wargo, J. A. AU - Ribas, A. PY - 2017 DA - 2017// TI - Primary, adaptive, and acquired resistance to cancer immunotherapy JO - Cell VL - 168 UR - https://doi.org/10.1016/j.cell.2017.01.017 DO - 10.1016/j.cell.2017.01.017 ID - Sharma2017 ER - TY - JOUR AU - Hüser, N. AU - Michalski, C. W. AU - Erkan, M. AU - Schuster, T. AU - Rosenberg, R. AU - Kleeff, J. PY - 2008 DA - 2008// TI - Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery JO - Ann Surg VL - 248 UR - https://doi.org/10.1097/SLA.0b013e318176bf65 DO - 10.1097/SLA.0b013e318176bf65 ID - Hüser2008 ER - TY - JOUR AU - Whitson, B. A. AU - Groth, S. S. AU - Duval, S. J. AU - Swanson, S. J. AU - Maddaus, M. A. PY - 2008 DA - 2008// TI - Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy JO - Ann Thorac Surg VL - 86 UR - https://doi.org/10.1016/j.athoracsur.2008.07.009 DO - 10.1016/j.athoracsur.2008.07.009 ID - Whitson2008 ER - TY - JOUR AU - Green, J. A. AU - Kirwan, J. M. AU - Tierney, J. F. AU - Symonds, P. AU - Fresco, L. AU - Collingwood, M. PY - 2001 DA - 2001// TI - Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis JO - Lancet. VL - 358 UR - https://doi.org/10.1016/S0140-6736(01)05965-7 DO - 10.1016/S0140-6736(01)05965-7 ID - Green2001 ER - TY - JOUR AU - Ronckers, C. M. AU - Erdmann, C. A. AU - Land, C. E. PY - 2005 DA - 2005// TI - Radiation and breast cancer: a review of current evidence JO - Breast Cancer Res VL - 7 UR - https://doi.org/10.1186/bcr970 DO - 10.1186/bcr970 ID - Ronckers2005 ER - TY - JOUR AU - Barton, M. K. PY - 2015 DA - 2015// TI - Daily aspirin may reduce mortality from prostate cancer with risk of high recurrence JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21263 DO - 10.3322/caac.21263 ID - Barton2015 ER - TY - JOUR AU - Yang, B. AU - Liu, T. AU - Qu, Y. AU - Liu, H. AU - Zheng, S. G. AU - Cheng, B. PY - 2018 DA - 2018// TI - Progresses and perspectives of anti-PD-1/PD-L1 antibody therapy in head and neck cancers JO - Front Oncol VL - 8 UR - https://doi.org/10.3389/fonc.2018.00563 DO - 10.3389/fonc.2018.00563 ID - Yang2018 ER - TY - JOUR AU - Palmerini, E. AU - Picci, P. AU - Reichardt, P. AU - Downey, G. PY - 2019 DA - 2019// TI - Malignancy in Giant cell tumor of bone: a review of the literature JO - Technol Cancer Res Treat VL - 18 UR - https://doi.org/10.1177/1533033819840000 DO - 10.1177/1533033819840000 ID - Palmerini2019 ER - TY - JOUR AU - Gong, Y. AU - Fan, Z. AU - Luo, G. AU - Yang, C. AU - Huang, Q. AU - Fan, K. PY - 2019 DA - 2019// TI - The role of necroptosis in cancer biology and therapy JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-1029-8 DO - 10.1186/s12943-019-1029-8 ID - Gong2019 ER - TY - JOUR AU - Oei, S. L. AU - Thronicke, A. AU - Schad, F. PY - 2019 DA - 2019// TI - Mistletoe and immunomodulation: insights and implications for anticancer therapies JO - Evid Based Complement Alternat Med VL - 2019 UR - https://doi.org/10.1155/2019/5893017 DO - 10.1155/2019/5893017 ID - Oei2019 ER - TY - STD TI - Ritchie C, Cordova AF, Hess GT, Bassik MC, Li L. SLC19A1 Is an Importer of the Immunotransmitter cGAMP. Mol Cell. 2019;75(2):372-81 e5. PMC6711396. ID - ref14 ER - TY - STD TI - Salminen A, Kauppinen A, Kaarniranta K. AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging. J Mol Med (Berl). 2019;97(8):1049-64. PMC6647228. ID - ref15 ER - TY - JOUR AU - Ghate, K. AU - Amir, E. AU - Kuksis, M. AU - Hernandez-Barajas, D. AU - Rodriguez-Romo, L. AU - Booth, C. M. PY - 2019 DA - 2019// TI - PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: a meta-analysis JO - Cancer Treat Rev VL - 76 UR - https://doi.org/10.1016/j.ctrv.2019.05.002 DO - 10.1016/j.ctrv.2019.05.002 ID - Ghate2019 ER - TY - STD TI - Haddad R, Concha-Benavente F, Blumenschein G Jr., Fayette J, Guigay J, Colevas AD, et al. Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial. Cancer. 2019;125(18):3208-18. PMC6771504. ID - ref17 ER - TY - JOUR AU - Inokuchi, J. AU - Eto, M. PY - 2019 DA - 2019// TI - Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma JO - Cancer Manag Res VL - 11 UR - https://doi.org/10.2147/CMAR.S167708 DO - 10.2147/CMAR.S167708 ID - Inokuchi2019 ER - TY - STD TI - Kasherman L, Siu DHW, Lee KWC, Lord S, Marschner I, Lewis CR, et al. Efficacy of immune checkpoint inhibitors in older adults with advanced stage cancers: A meta-analysis. J Geriatr Oncol. 2019. ID - ref19 ER - TY - JOUR AU - Leventis, P. A. AU - Grinstein, S. PY - 2010 DA - 2010// TI - The distribution and function of phosphatidylserine in cellular membranes JO - Annu Rev Biophys VL - 39 UR - https://doi.org/10.1146/annurev.biophys.093008.131234 DO - 10.1146/annurev.biophys.093008.131234 ID - Leventis2010 ER - TY - JOUR AU - Fadok, V. A. AU - Bratton, D. L. AU - Frasch, S. C. AU - Warner, M. L. AU - Henson, P. M. PY - 1998 DA - 1998// TI - The role of phosphatidylserine in recognition of apoptotic cells by phagocytes JO - Cell Death Differ VL - 5 UR - https://doi.org/10.1038/sj.cdd.4400404 DO - 10.1038/sj.cdd.4400404 ID - Fadok1998 ER - TY - JOUR AU - Fadeel, B. AU - Xue, D. PY - 2009 DA - 2009// TI - The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease JO - Crit Rev Biochem Mol Biol VL - 44 UR - https://doi.org/10.1080/10409230903193307 DO - 10.1080/10409230903193307 ID - Fadeel2009 ER - TY - JOUR AU - Kumar, S. AU - Birge, R. B. PY - 2016 DA - 2016// TI - Efferocytosis JO - Curr Biol VL - 26 UR - https://doi.org/10.1016/j.cub.2016.01.059 DO - 10.1016/j.cub.2016.01.059 ID - Kumar2016 ER - TY - JOUR AU - Nagata, S. PY - 2018 DA - 2018// TI - Apoptosis and clearance of apoptotic cells JO - Annu Rev Immunol VL - 36 UR - https://doi.org/10.1146/annurev-immunol-042617-053010 DO - 10.1146/annurev-immunol-042617-053010 ID - Nagata2018 ER - TY - JOUR AU - Vance, J. E. AU - Tasseva, G. PY - 2013 DA - 2013// TI - Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells JO - Biochim Biophys Acta VL - 1831 UR - https://doi.org/10.1016/j.bbalip.2012.08.016 DO - 10.1016/j.bbalip.2012.08.016 ID - Vance2013 ER - TY - JOUR AU - Sakuragi, T. AU - Kosako, H. AU - Nagata, S. PY - 2019 DA - 2019// TI - Phosphorylation-mediated activation of mouse Xkr8 scramblase for phosphatidylserine exposure JO - Proc Natl Acad Sci U S A VL - 116 UR - https://doi.org/10.1073/pnas.1820499116 DO - 10.1073/pnas.1820499116 ID - Sakuragi2019 ER - TY - JOUR AU - Belzile, O. AU - Huang, X. AU - Gong, J. AU - Carlson, J. AU - Schroit, A. J. AU - Brekken, R. A. PY - 2018 DA - 2018// TI - Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer JO - Immunotargets Ther VL - 7 UR - https://doi.org/10.2147/ITT.S134834 DO - 10.2147/ITT.S134834 ID - Belzile2018 ER - TY - JOUR AU - Birge, R. B. AU - Boeltz, S. AU - Kumar, S. AU - Carlson, J. AU - Wanderley, J. AU - Calianese, D. PY - 2016 DA - 2016// TI - Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer JO - Cell Death Differ VL - 23 UR - https://doi.org/10.1038/cdd.2016.11 DO - 10.1038/cdd.2016.11 ID - Birge2016 ER - TY - JOUR AU - Gabrilovich, D. I. PY - 2017 DA - 2017// TI - Myeloid-derived suppressor cells JO - Cancer Immunol Res VL - 5 UR - https://doi.org/10.1158/2326-6066.CIR-16-0297 DO - 10.1158/2326-6066.CIR-16-0297 ID - Gabrilovich2017 ER - TY - JOUR AU - Utsugi, T. AU - Schroit, A. J. AU - Connor, J. AU - Bucana, C. D. AU - Fidler, I. J. PY - 1991 DA - 1991// TI - Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes JO - Cancer Res VL - 51 ID - Utsugi1991 ER - TY - JOUR AU - Koopman, G. AU - Reutelingsperger, C. AU - Kuijten, G. AU - Keehnen, R. AU - Pals, S. AU - Oers, M. PY - 1994 DA - 1994// TI - Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis JO - Blood VL - 84 UR - https://doi.org/10.1182/blood.V84.5.1415.bloodjournal8451415 DO - 10.1182/blood.V84.5.1415.bloodjournal8451415 ID - Koopman1994 ER - TY - JOUR AU - Doffek, K. AU - Chen, X. AU - Sugg, S. L. AU - Shilyansky, J. PY - 2011 DA - 2011// TI - Phosphatidylserine inhibits NFkappaB and p38 MAPK activation in human monocyte derived dendritic cells JO - Mol Immunol VL - 48 UR - https://doi.org/10.1016/j.molimm.2011.04.021 DO - 10.1016/j.molimm.2011.04.021 ID - Doffek2011 ER - TY - JOUR AU - Fischer, K. AU - Voelkl, S. AU - Berger, J. AU - Andreesen, R. AU - Pomorski, T. AU - Mackensen, A. PY - 2006 DA - 2006// TI - Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells JO - Blood VL - 108 UR - https://doi.org/10.1182/blood-2006-03-011742 DO - 10.1182/blood-2006-03-011742 ID - Fischer2006 ER - TY - JOUR AU - Martin, S. AU - Pombo, I. AU - Poncet, P. AU - David, B. AU - Arock, M. AU - Blank, U. PY - 2000 DA - 2000// TI - Immunologic stimulation of mast cells leads to the reversible exposure of phosphatidylserine in the absence of apoptosis JO - Int Arch Allergy Immunol VL - 123 UR - https://doi.org/10.1159/000024451 DO - 10.1159/000024451 ID - Martin2000 ER - TY - JOUR AU - Wu, X. AU - Yao, Z. AU - Zhao, L. AU - Zhang, Y. AU - Cao, M. AU - Li, T. PY - 2016 DA - 2016// TI - Phosphatidylserine on blood cells and endothelial cells contributes to the hypercoagulable state in cirrhosis JO - Liver Int VL - 36 UR - https://doi.org/10.1111/liv.13167 DO - 10.1111/liv.13167 ID - Wu2016 ER - TY - JOUR AU - Moller-Tank, S. AU - Maury, W. PY - 2014 DA - 2014// TI - Phosphatidylserine receptors: enhancers of enveloped virus entry and infection JO - Virology VL - 468–470 UR - https://doi.org/10.1016/j.virol.2014.09.009 DO - 10.1016/j.virol.2014.09.009 ID - Moller-Tank2014 ER - TY - JOUR AU - Moller-Tank, S. AU - Albritton, L. M. AU - Rennert, P. D. AU - Maury, W. PY - 2014 DA - 2014// TI - Characterizing functional domains for TIM-mediated enveloped virus entry JO - J Virol VL - 88 UR - https://doi.org/10.1128/JVI.00300-14 DO - 10.1128/JVI.00300-14 ID - Moller-Tank2014 ER - TY - JOUR AU - Yeung, M. Y. AU - Ding, Q. AU - Brooks, C. R. AU - Xiao, S. AU - Workman, C. J. AU - Vignali, D. A. A. PY - 2015 DA - 2015// TI - TIM-1 signaling is required for maintenance and induction of regulatory B cells JO - Am J Transplant VL - 15 UR - https://doi.org/10.1111/ajt.13087 DO - 10.1111/ajt.13087 ID - Yeung2015 ER - TY - JOUR AU - Park, D. AU - Hochreiter-Hufford, A. AU - Ravichandran, K. S. PY - 2009 DA - 2009// TI - The Phosphatidylserine receptor TIM-4 does not mediate direct signaling JO - Curr Biol VL - 19 UR - https://doi.org/10.1016/j.cub.2009.01.042 DO - 10.1016/j.cub.2009.01.042 ID - Park2009 ER - TY - JOUR AU - Graham, D. K. AU - DeRyckere, D. AU - Davies, K. D. AU - Earp, H. S. PY - 2014 DA - 2014// TI - The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer JO - Nat Rev Cancer VL - 14 UR - https://doi.org/10.1038/nrc3847 DO - 10.1038/nrc3847 ID - Graham2014 ER - TY - JOUR AU - Pittoni, V. AU - Isenberg, D. PY - 1998 DA - 1998// TI - Apoptosis and antiphospholipid antibodies JO - Semin Arthritis Rheum VL - 28 UR - https://doi.org/10.1016/S0049-0172(98)80033-4 DO - 10.1016/S0049-0172(98)80033-4 ID - Pittoni1998 ER - TY - JOUR AU - DeRose, P. AU - Thorpe, P. E. AU - Gerber, D. E. PY - 2011 DA - 2011// TI - Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment JO - Immunotherapy VL - 3 UR - https://doi.org/10.2217/imt.11.87 DO - 10.2217/imt.11.87 ID - DeRose2011 ER - TY - JOUR AU - He, Y. AU - Cao, J. AU - Zhao, C. AU - Li, X. AU - Zhou, C. AU - Hirsch, F. R. PY - 2018 DA - 2018// TI - TIM-3, a promising target for cancer immunotherapy JO - Onco Targets Ther VL - 11 UR - https://doi.org/10.2147/OTT.S170385 DO - 10.2147/OTT.S170385 ID - He2018 ER - TY - JOUR AU - Ocana-Guzman, R. AU - Torre-Bouscoulet, L. AU - Sada-Ovalle, I. PY - 2016 DA - 2016// TI - TIM-3 regulates distinct functions in macrophages JO - Front Immunol VL - 7 UR - https://doi.org/10.3389/fimmu.2016.00229 DO - 10.3389/fimmu.2016.00229 ID - Ocana-Guzman2016 ER - TY - JOUR AU - Freeman, G. J. AU - Casasnovas, J. M. AU - Umetsu, D. T. AU - DeKruyff, R. H. PY - 2010 DA - 2010// TI - TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity JO - Immunol Rev VL - 235 UR - https://doi.org/10.1111/j.0105-2896.2010.00903.x DO - 10.1111/j.0105-2896.2010.00903.x ID - Freeman2010 ER - TY - JOUR AU - Das, M. AU - Zhu, C. AU - Kuchroo, V. K. PY - 2017 DA - 2017// TI - Tim-3 and its role in regulating anti-tumor immunity JO - Immunol Rev VL - 276 UR - https://doi.org/10.1111/imr.12520 DO - 10.1111/imr.12520 ID - Das2017 ER - TY - JOUR AU - Thomas, L. J. AU - Vitale, L. AU - O'Neill, T. AU - Dolnick, R. Y. AU - Wallace, P. K. AU - Minderman, H. PY - 2016 DA - 2016// TI - Development of a novel antibody-drug conjugate for the potential treatment of ovarian, lung, and renal cell carcinoma expressing TIM-1 JO - Mol Cancer Ther VL - 15 UR - https://doi.org/10.1158/1535-7163.MCT-16-0393 DO - 10.1158/1535-7163.MCT-16-0393 ID - Thomas2016 ER - TY - JOUR AU - Wang, Y. AU - Sun, J. AU - Gao, W. AU - Song, B. AU - Shao, Q. AU - Zhao, L. PY - 2017 DA - 2017// TI - Preoperative Tim3 expression on peripheral NK cells is correlated with pathologic TNM staging in colorectal cancer JO - Mol Med Rep VL - 15 UR - https://doi.org/10.3892/mmr.2017.6482 DO - 10.3892/mmr.2017.6482 ID - Wang2017 ER - TY - JOUR AU - Martin-Manzo, M. V. AU - Lara, C. AU - Vargas-de-Leon, C. AU - Carrero, J. AU - Queipo, G. AU - Fonseca-Sanchez, M. PY - 2019 DA - 2019// TI - Interaction of breast cancer and insulin resistance on PD1 and TIM3 expression in peripheral blood CD8 T cells JO - Pathol Oncol Res VL - 25 UR - https://doi.org/10.1007/s12253-019-00610-7 DO - 10.1007/s12253-019-00610-7 ID - Martin-Manzo2019 ER - TY - JOUR AU - Liu, J. F. AU - Wu, L. AU - Yang, L. L. AU - Deng, W. W. AU - Mao, L. AU - Wu, H. PY - 2018 DA - 2018// TI - Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer JO - J Exp Clin Cancer Res VL - 37 UR - https://doi.org/10.1186/s13046-018-0713-7 DO - 10.1186/s13046-018-0713-7 ID - Liu2018 ER - TY - JOUR AU - Hervas-Stubbs, S. AU - Soldevilla, M. M. AU - Villanueva, H. AU - Mancheno, U. AU - Bendandi, M. AU - Pastor, F. PY - 2016 DA - 2016// TI - Identification of TIM3 2′-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.6608 DO - 10.18632/oncotarget.6608 ID - Hervas-Stubbs2016 ER - TY - JOUR AU - Mingo, P. A. AU - Gardner, A. AU - Hiebler, S. AU - Soliman, H. AU - Rugo, H. S. AU - Krummel, M. F. PY - 2018 DA - 2018// TI - TIM-3 regulates CD103(+) dendritic cell function and response to chemotherapy in breast cancer JO - Cancer Cell VL - 33 UR - https://doi.org/10.1016/j.ccell.2017.11.019 DO - 10.1016/j.ccell.2017.11.019 ID - Mingo2018 ER - TY - JOUR AU - Dong, J. AU - Cheng, L. AU - Zhao, M. AU - Pan, X. AU - Feng, Z. AU - Wang, D. PY - 2017 DA - 2017// TI - Tim-3-expressing macrophages are functionally suppressed and expanded in oral squamous cell carcinoma due to virus-induced Gal-9 expression JO - Tumour Biol VL - 39 UR - https://doi.org/10.1177/1010428317701651 DO - 10.1177/1010428317701651 ID - Dong2017 ER - TY - JOUR AU - Yan, W. AU - Liu, X. AU - Ma, H. AU - Zhang, H. AU - Song, X. AU - Gao, L. PY - 2015 DA - 2015// TI - Tim-3 fosters HCC development by enhancing TGF-beta-mediated alternative activation of macrophages JO - Gut VL - 64 UR - https://doi.org/10.1136/gutjnl-2014-307671 DO - 10.1136/gutjnl-2014-307671 ID - Yan2015 ER - TY - JOUR AU - Li, Y. M. AU - Li, Y. AU - Yan, L. AU - Tang, J. T. AU - Wu, X. J. AU - Bai, Y. J. PY - 2019 DA - 2019// TI - Assessment of serum Tim-3 and Gal-9 levels in predicting the risk of infection after kidney transplantation JO - Int Immunopharmacol VL - 75 UR - https://doi.org/10.1016/j.intimp.2019.105803 DO - 10.1016/j.intimp.2019.105803 ID - Li2019 ER - TY - JOUR AU - Ye, L. AU - Zhang, Q. AU - Cheng, Y. AU - Chen, X. AU - Wang, G. AU - Shi, M. PY - 2018 DA - 2018// TI - Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion JO - J Immunother Cancer VL - 6 UR - https://doi.org/10.1186/s40425-018-0451-6 DO - 10.1186/s40425-018-0451-6 ID - Ye2018 ER - TY - JOUR AU - Wang, Y. AU - Zhao, E. AU - Zhang, Z. AU - Zhao, G. AU - Cao, H. PY - 2018 DA - 2018// TI - Association between Tim3 and Gal9 expression and gastric cancer prognosis JO - Oncol Rep VL - 40 UR - https://doi.org/10.3892/or.2015.4170 DO - 10.3892/or.2015.4170 ID - Wang2018 ER - TY - JOUR AU - Cheng, X. AU - Li, L. AU - Thorpe, P. E. AU - Yopp, A. C. AU - Brekken, R. A. AU - Huang, X. PY - 2016 DA - 2016// TI - Antibody-mediated blockade of phosphatidylserine enhances the antitumor effect of Sorafenib in hepatocellular carcinomas xenografts JO - Ann Surg Oncol VL - 23 UR - https://doi.org/10.1245/s10434-016-5107-5 DO - 10.1245/s10434-016-5107-5 ID - Cheng2016 ER - TY - JOUR AU - Tang, D. AU - Lotze, M. T. PY - 2012 DA - 2012// TI - Tumor immunity times out: TIM-3 and HMGB1 JO - Nat Immunol VL - 13 UR - https://doi.org/10.1038/ni.2396 DO - 10.1038/ni.2396 ID - Tang2012 ER - TY - JOUR AU - Cao, E. AU - Zang, X. AU - Ramagopal, U. A. AU - Mukhopadhaya, A. AU - Fedorov, A. AU - Fedorov, E. PY - 2007 DA - 2007// TI - T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface JO - Immunity VL - 26 UR - https://doi.org/10.1016/j.immuni.2007.01.016 DO - 10.1016/j.immuni.2007.01.016 ID - Cao2007 ER - TY - JOUR AU - Nakayama, M. AU - Akiba, H. AU - Takeda, K. AU - Kojima, Y. AU - Hashiguchi, M. AU - Azuma, M. PY - 2009 DA - 2009// TI - Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-10-185884 DO - 10.1182/blood-2008-10-185884 ID - Nakayama2009 ER - TY - JOUR AU - DeKruyff, R. H. AU - Bu, X. AU - Ballesteros, A. AU - Santiago, C. AU - Chim, Y. -. L. E. AU - Lee, H. -. H. PY - 2010 DA - 2010// TI - T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells JO - J Immunol (Baltimore, Md : 1950) VL - 184 UR - https://doi.org/10.4049/jimmunol.0903059 DO - 10.4049/jimmunol.0903059 ID - DeKruyff2010 ER - TY - JOUR AU - Silva, I. P. AU - Gallois, A. AU - Jimenez-Baranda, S. AU - Khan, S. AU - Anderson, A. C. AU - Kuchroo, V. K. PY - 2014 DA - 2014// TI - Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade JO - Cancer Immunol Res VL - 2 UR - https://doi.org/10.1158/2326-6066.CIR-13-0171 DO - 10.1158/2326-6066.CIR-13-0171 ID - Silva2014 ER - TY - JOUR AU - Zhu, C. AU - Anderson, A. C. AU - Schubart, A. AU - Xiong, H. AU - Imitola, J. AU - Khoury, S. J. PY - 2005 DA - 2005// TI - The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity JO - Nat Immunol VL - 6 UR - https://doi.org/10.1038/ni1271 DO - 10.1038/ni1271 ID - Zhu2005 ER - TY - JOUR AU - Nakae, S. AU - Iwakura, Y. AU - Suto, H. AU - Galli, S. J. PY - 2007 DA - 2007// TI - Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17 JO - J Leukoc Biol VL - 81 UR - https://doi.org/10.1189/jlb.1006610 DO - 10.1189/jlb.1006610 ID - Nakae2007 ER - TY - JOUR AU - Guo, Z. AU - Cheng, D. AU - Xia, Z. AU - Luan, M. AU - Wu, L. AU - Wang, G. PY - 2013 DA - 2013// TI - Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer JO - J Transl Med VL - 11 UR - https://doi.org/10.1186/1479-5876-11-215 DO - 10.1186/1479-5876-11-215 ID - Guo2013 ER - TY - JOUR AU - Qin, S. AU - Xu, L. AU - Yi, M. AU - Yu, S. AU - Wu, K. AU - Luo, S. PY - 2019 DA - 2019// TI - Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4 JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-1091-2 DO - 10.1186/s12943-019-1091-2 ID - Qin2019 ER - TY - JOUR AU - Sakuishi, K. AU - Apetoh, L. AU - Sullivan, J. M. AU - Blazar, B. R. AU - Kuchroo, V. K. AU - Anderson, A. C. PY - 2010 DA - 2010// TI - Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity JO - J Exp Med VL - 207 UR - https://doi.org/10.1084/jem.20100643 DO - 10.1084/jem.20100643 ID - Sakuishi2010 ER - TY - JOUR AU - Baitsch, L. AU - Baumgaertner, P. AU - Devevre, E. AU - Raghav, S. K. AU - Legat, A. AU - Barba, L. PY - 2011 DA - 2011// TI - Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients JO - J Clin Invest VL - 121 UR - https://doi.org/10.1172/JCI46102 DO - 10.1172/JCI46102 ID - Baitsch2011 ER - TY - JOUR AU - Hendry, S. AU - Salgado, R. AU - Gevaert, T. AU - Russell, P. A. AU - John, T. AU - Thapa, B. PY - 2017 DA - 2017// TI - Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors JO - Adv Anat Pathol VL - 24 UR - https://doi.org/10.1097/PAP.0000000000000161 DO - 10.1097/PAP.0000000000000161 ID - Hendry2017 ER - TY - JOUR AU - Fourcade, J. AU - Sun, Z. AU - Benallaoua, M. AU - Guillaume, P. AU - Luescher, I. F. AU - Sander, C. PY - 2010 DA - 2010// TI - Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients JO - J Exp Med VL - 207 UR - https://doi.org/10.1084/jem.20100637 DO - 10.1084/jem.20100637 ID - Fourcade2010 ER - TY - JOUR AU - Zhang, Y. AU - Ma, C. J. AU - Wang, J. M. AU - Ji, X. J. AU - Wu, X. Y. AU - Jia, Z. S. PY - 2011 DA - 2011// TI - Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0019664 DO - 10.1371/journal.pone.0019664 ID - Zhang2011 ER - TY - JOUR AU - Friedlaender, A. AU - Addeo, A. AU - Banna, G. PY - 2019 DA - 2019// TI - New emerging targets in cancer immunotherapy: the role of TIM3 JO - ESMO Open VL - 4 UR - https://doi.org/10.1136/esmoopen-2019-000497 DO - 10.1136/esmoopen-2019-000497 ID - Friedlaender2019 ER - TY - JOUR AU - Ndhlovu, L. C. AU - Lopez-Vergès, S. AU - Barbour, J. D. AU - Jones, R. B. AU - Jha, A. R. AU - Long, B. R. PY - 2012 DA - 2012// TI - Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-11-392951 DO - 10.1182/blood-2011-11-392951 ID - Ndhlovu2012 ER - TY - JOUR AU - Gleason, M. K. AU - Lenvik, T. R. AU - McCullar, V. AU - Felices, M. AU - O'Brien, M. S. AU - Cooley, S. A. PY - 2012 DA - 2012// TI - Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9 JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-06-360321 DO - 10.1182/blood-2011-06-360321 ID - Gleason2012 ER - TY - JOUR AU - Linger, R. M. AU - Keating, A. K. AU - Earp, H. S. AU - Graham, D. K. PY - 2008 DA - 2008// TI - TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer JO - Adv Cancer Res VL - 100 UR - https://doi.org/10.1016/S0065-230X(08)00002-X DO - 10.1016/S0065-230X(08)00002-X ID - Linger2008 ER - TY - JOUR AU - Ludwig, K. F. AU - Du, W. AU - Sorrelle, N. B. AU - Wnuk-Lipinska, K. AU - Topalovski, M. AU - Toombs, J. E. PY - 2018 DA - 2018// TI - Small-molecule inhibition of Axl targets tumor immune suppression and enhances chemotherapy in pancreatic cancer JO - Cancer Res VL - 78 UR - https://doi.org/10.1158/0008-5472.CAN-17-1973 DO - 10.1158/0008-5472.CAN-17-1973 ID - Ludwig2018 ER - TY - JOUR AU - Du, W. AU - Brekken, R. A. PY - 2018 DA - 2018// TI - Does Axl have potential as a therapeutic target in pancreatic cancer? JO - Expert Opin Ther Targets VL - 22 UR - https://doi.org/10.1080/14728222.2018.1527315 DO - 10.1080/14728222.2018.1527315 ID - Du2018 ER - TY - JOUR AU - Williams, J. C. AU - Craven, R. R. AU - Earp, H. S. AU - Kawula, T. H. AU - Matsushima, G. K. PY - 2009 DA - 2009// TI - TAM receptors are dispensable in the phagocytosis and killing of bacteria JO - Cell Immunol VL - 259 UR - https://doi.org/10.1016/j.cellimm.2009.06.006 DO - 10.1016/j.cellimm.2009.06.006 ID - Williams2009 ER - TY - JOUR AU - Qingxian, L. AU - Qiutang, L. AU - Qingjun, L. PY - 2010 DA - 2010// TI - Regulation of phagocytosis by TAM receptors and their ligands JO - Front Biol (Beijing) VL - 5 UR - https://doi.org/10.1007/s11515-010-0034-5 DO - 10.1007/s11515-010-0034-5 ID - Qingxian2010 ER - TY - STD TI - Paolino M, Penninger JM. The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy. Cancers (Basel). 2016;8(10). https://doi.org/10.3390/cancers8100097. PMC5082387. ID - ref81 ER - TY - JOUR AU - Scutera, S. AU - Fraone, T. AU - Musso, T. AU - Cappello, P. AU - Rossi, S. AU - Pierobon, D. PY - 2009 DA - 2009// TI - Survival and migration of human dendritic cells are regulated by an IFN-alpha-inducible Axl/Gas6 pathway JO - J Immunol VL - 183 UR - https://doi.org/10.4049/jimmunol.0804384 DO - 10.4049/jimmunol.0804384 ID - Scutera2009 ER - TY - JOUR AU - O'Neill, L. A. PY - 2007 DA - 2007// TI - TAMpering with toll-like receptor signaling JO - Cell VL - 131 UR - https://doi.org/10.1016/j.cell.2007.11.032 DO - 10.1016/j.cell.2007.11.032 ID - O'Neill2007 ER - TY - JOUR AU - Cook, R. S. AU - Jacobsen, K. M. AU - Wofford, A. M. AU - DeRyckere, D. AU - Stanford, J. AU - Prieto, A. L. PY - 2013 DA - 2013// TI - MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis JO - J Clin Invest VL - 123 UR - https://doi.org/10.1172/JCI67655 DO - 10.1172/JCI67655 ID - Cook2013 ER - TY - JOUR AU - Loges, S. AU - Schmidt, T. AU - Tjwa, M. AU - Geyte, K. AU - Lievens, D. AU - Lutgens, E. PY - 2010 DA - 2010// TI - Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6 JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-06-228684 DO - 10.1182/blood-2009-06-228684 ID - Loges2010 ER - TY - JOUR AU - Lemke, G. AU - Rothlin, C. V. PY - 2008 DA - 2008// TI - Immunobiology of the TAM receptors JO - Nat Rev Immunol VL - 8 UR - https://doi.org/10.1038/nri2303 DO - 10.1038/nri2303 ID - Lemke2008 ER - TY - JOUR AU - Smith, B. N. AU - Bhowmick, N. A. PY - 2016 DA - 2016// TI - Role of EMT in metastasis and therapy resistance JO - J Clin Med VL - 5 UR - https://doi.org/10.3390/jcm5020017 DO - 10.3390/jcm5020017 ID - Smith2016 ER - TY - JOUR AU - Terry, S. AU - Savagner, P. AU - Ortiz-Cuaran, S. AU - Mahjoubi, L. AU - Saintigny, P. AU - Thiery, J. -. P. PY - 2017 DA - 2017// TI - New insights into the role of EMT in tumor immune escape JO - Mol Oncol VL - 11 UR - https://doi.org/10.1002/1878-0261.12093 DO - 10.1002/1878-0261.12093 ID - Terry2017 ER - TY - JOUR AU - Demarest, S. J. AU - Gardner, J. AU - Vendel, M. C. AU - Ailor, E. AU - Szak, S. AU - Huang, F. PY - 2013 DA - 2013// TI - Evaluation of Tyro3 expression, Gas6-mediated Akt phosphorylation, and the impact of anti-Tyro3 antibodies in melanoma cell lines JO - Biochemistry VL - 52 UR - https://doi.org/10.1021/bi301588c DO - 10.1021/bi301588c ID - Demarest2013 ER - TY - JOUR AU - Chien, C. W. AU - Hou, P. C. AU - Wu, H. C. AU - Chang, Y. L. AU - Lin, S. C. AU - Lin, S. C. PY - 2016 DA - 2016// TI - Targeting TYRO3 inhibits epithelial–mesenchymal transition and increases drug sensitivity in colon cancer JO - Oncogene VL - 35 UR - https://doi.org/10.1038/onc.2016.120 DO - 10.1038/onc.2016.120 ID - Chien2016 ER - TY - JOUR AU - Shao, H. AU - Wang, A. AU - Lauffenburger, D. AU - Wells, A. PY - 2018 DA - 2018// TI - Tyro3-mediated phosphorylation of ACTN4 at tyrosines is FAK-dependent and decreases susceptibility to cleavage by m-Calpain JO - Int J Biochem Cell Biol VL - 95 UR - https://doi.org/10.1016/j.biocel.2017.12.014 DO - 10.1016/j.biocel.2017.12.014 ID - Shao2018 ER - TY - JOUR AU - Wu, G. AU - Ma, Z. AU - Cheng, Y. AU - Hu, W. AU - Deng, C. AU - Jiang, S. PY - 2018 DA - 2018// TI - Targeting Gas6/TAM in cancer cells and tumor microenvironment JO - Mol Cancer VL - 17 UR - https://doi.org/10.1186/s12943-018-0769-1 DO - 10.1186/s12943-018-0769-1 ID - Wu2018 ER - TY - JOUR AU - Kabir, T. D. AU - Ganda, C. AU - Brown, R. M. AU - Beveridge, D. J. AU - Richardson, K. L. AU - Chaturvedi, V. PY - 2018 DA - 2018// TI - A microRNA-7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma JO - Hepatology VL - 67 UR - https://doi.org/10.1002/hep.29478 DO - 10.1002/hep.29478 ID - Kabir2018 ER - TY - JOUR AU - Baumann, C. AU - Ullrich, A. AU - Torka, R. PY - 2017 DA - 2017// TI - GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance JO - Mol Oncol VL - 11 UR - https://doi.org/10.1002/1878-0261.12109 DO - 10.1002/1878-0261.12109 ID - Baumann2017 ER - TY - JOUR AU - Akalu, Y. T. AU - Rothlin, C. V. AU - Ghosh, S. PY - 2017 DA - 2017// TI - TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy JO - Immunol Rev VL - 276 UR - https://doi.org/10.1111/imr.12522 DO - 10.1111/imr.12522 ID - Akalu2017 ER - TY - JOUR AU - Smart, S. K. AU - Vasileiadi, E. AU - Wang, X. AU - DeRyckere, D. AU - Graham, D. K. PY - 2018 DA - 2018// TI - The emerging role of TYRO3 as a therapeutic target in cancer JO - Cancers VL - 10 UR - https://doi.org/10.3390/cancers10120474 DO - 10.3390/cancers10120474 ID - Smart2018 ER - TY - JOUR AU - Duan, Y. AU - Luo, L. AU - Qiao, C. AU - Li, X. AU - Wang, J. AU - Liu, H. PY - 2019 DA - 2019// TI - A novel human anti-AXL monoclonal antibody attenuates tumour cell migration JO - Scand J Immunol VL - 90 UR - https://doi.org/10.1111/sji.12777 DO - 10.1111/sji.12777 ID - Duan2019 ER - TY - JOUR AU - Sharp, L. L. AU - Chang, C. AU - Frey, G. AU - Wang, J. AU - Liu, H. AU - Xing, C. PY - 2018 DA - 2018// TI - Abstract 827: Anti-tumor efficacy of BA3011, a novel Conditionally Active Biologic (CAB) anti-AXL-ADC JO - Cancer Res VL - 78 ID - Sharp2018 ER - TY - JOUR AU - Ye, X. AU - Li, Y. AU - Stawicki, S. AU - Couto, S. AU - Eastham-Anderson, J. AU - Kallop, D. PY - 2010 DA - 2010// TI - An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2010.268 DO - 10.1038/onc.2010.268 ID - Ye2010 ER - TY - JOUR AU - Okimoto, R. A. AU - Bivona, T. G. PY - 2015 DA - 2015// TI - AXL receptor tyrosine kinase as a therapeutic target in NSCLC JO - Lung Cancer (Auckl) VL - 6 ID - Okimoto2015 ER - TY - JOUR AU - Leconet, W. AU - Chentouf, M. AU - Manoir, S. AU - Chevalier, C. AU - Sirvent, A. AU - Ait-Arsa, I. PY - 2017 DA - 2017// TI - Therapeutic activity of anti-AXL antibody against triple-negative breast cancer patient-derived xenografts and metastasis JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-1316 DO - 10.1158/1078-0432.CCR-16-1316 ID - Leconet2017 ER - TY - JOUR AU - Takeda, S. AU - Andreu-Agullo, C. AU - Sridhar, S. AU - Halberg, N. AU - Lorenz, I. C. AU - Tavazoie, S. PY - 2019 DA - 2019// TI - Abstract LB-277: Characterization of the anti-cancer and immunologic activity of RGX-019, a novel pre-clinical stage humanized monoclonal antibody targeting the MERTK receptor JO - Cancer Res VL - 79 ID - Takeda2019 ER - TY - JOUR AU - Cummings, C. T. AU - Linger, R. M. AU - Cohen, R. A. AU - Sather, S. AU - Kirkpatrick, G. D. AU - Davies, K. D. PY - 2014 DA - 2014// TI - Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer JO - Oncotarget VL - 5 UR - https://doi.org/10.18632/oncotarget.2142 DO - 10.18632/oncotarget.2142 ID - Cummings2014 ER - TY - STD TI - Du W, Huang H, Sorrelle N, Brekken RA. Sitravatinib potentiates immune checkpoint blockade in refractory cancer models. JCI Insight. 2018;3(21). https://doi.org/10.1172/jci.insight.124184. PMC6238734. ID - ref104 ER - TY - JOUR AU - Kasikara, C. AU - Davra, V. AU - Calianese, D. AU - Geng, K. AU - Spires, T. E. AU - Quigley, M. PY - 2019 DA - 2019// TI - Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti-PD-1 mAb efficacy in a murine model of triple-negative breast cancer JO - Cancer Res VL - 79 UR - https://doi.org/10.1158/0008-5472.CAN-18-2614 DO - 10.1158/0008-5472.CAN-18-2614 ID - Kasikara2019 ER - TY - JOUR AU - Ran, S. AU - Gao, B. AU - Duffy, S. AU - Watkins, L. AU - Rote, N. AU - Thorpe, P. E. PY - 1998 DA - 1998// TI - Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature JO - Cancer Res VL - 58 ID - Ran1998 ER - TY - JOUR AU - Ran, S. AU - Thorpe, P. E. PY - 2002 DA - 2002// TI - Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy JO - Int J Radiat Oncol Biol Phys VL - 54 UR - https://doi.org/10.1016/S0360-3016(02)03928-7 DO - 10.1016/S0360-3016(02)03928-7 ID - Ran2002 ER - TY - JOUR AU - Ran, S. AU - Downes, A. AU - Thorpe, P. E. PY - 2002 DA - 2002// TI - Increased exposure of anionic phospholipids on the surface of tumor blood vessels JO - Cancer Res VL - 62 ID - Ran2002 ER - TY - JOUR AU - Balasubramanian, K. AU - Schroit, A. J. PY - 1998 DA - 1998// TI - Characterization of phosphatidylserine-dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes JO - J Biol Chem VL - 273 UR - https://doi.org/10.1074/jbc.273.44.29272 DO - 10.1074/jbc.273.44.29272 ID - Balasubramanian1998 ER - TY - JOUR AU - Groot, P. G. AU - Meijers, J. C. PY - 2011 DA - 2011// TI - Beta(2) -glycoprotein I: evolution, structure and function JO - J Thromb Haemost VL - 9 UR - https://doi.org/10.1111/j.1538-7836.2011.04327.x DO - 10.1111/j.1538-7836.2011.04327.x ID - Groot2011 ER - TY - JOUR AU - Luster, T. A. AU - He, J. AU - Huang, X. AU - Maiti, S. N. AU - Schroit, A. J. AU - Groot, P. G. PY - 2006 DA - 2006// TI - Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells JO - J Biol Chem VL - 281 UR - https://doi.org/10.1074/jbc.M605252200 DO - 10.1074/jbc.M605252200 ID - Luster2006 ER - TY - JOUR AU - Ran, S. AU - He, J. AU - Huang, X. AU - Soares, M. AU - Scothorn, D. AU - Thorpe, P. E. PY - 2005 DA - 2005// TI - Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-1645 DO - 10.1158/1078-0432.CCR-04-1645 ID - Ran2005 ER - TY - JOUR AU - Huang, X. AU - Bennett, M. AU - Thorpe, P. E. PY - 2005 DA - 2005// TI - A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of Docetaxel on human breast tumors in mice JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-0031 DO - 10.1158/0008-5472.CAN-05-0031 ID - Huang2005 ER - TY - JOUR AU - Beck, A. W. AU - Luster, T. A. AU - Miller, A. F. AU - Holloway, S. E. AU - Conner, C. R. AU - Barnett, C. C. PY - 2006 DA - 2006// TI - Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice JO - Int J Cancer VL - 118 UR - https://doi.org/10.1002/ijc.21684 DO - 10.1002/ijc.21684 ID - Beck2006 ER - TY - JOUR AU - He, J. AU - Yin, Y. AU - Luster, T. A. AU - Watkins, L. AU - Thorpe, P. E. PY - 2009 DA - 2009// TI - Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-1499 DO - 10.1158/1078-0432.CCR-09-1499 ID - He2009 ER - TY - JOUR AU - He, J. AU - Luster, T. A. AU - Thorpe, P. E. PY - 2007 DA - 2007// TI - Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-0793 DO - 10.1158/1078-0432.CCR-07-0793 ID - He2007 ER - TY - JOUR AU - Mineo, C. AU - Lanier, L. AU - Jung, E. AU - Sengupta, S. AU - Ulrich, V. AU - Sacharidou, A. PY - 2016 DA - 2016// TI - Identification of a monoclonal antibody that attenuates antiphospholipid syndrome-related pregnancy complications and thrombosis JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0158757 DO - 10.1371/journal.pone.0158757 ID - Mineo2016 ER - TY - JOUR AU - Rahko, E. AU - Blanco, G. AU - Soini, Y. AU - Bloigu, R. AU - Jukkola, A. PY - 2003 DA - 2003// TI - A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients JO - Eur J Cancer VL - 39 UR - https://doi.org/10.1016/S0959-8049(02)00499-9 DO - 10.1016/S0959-8049(02)00499-9 ID - Rahko2003 ER - TY - JOUR AU - Liang, Y. AU - Besch-Williford, C. AU - Benakanakere, I. AU - Thorpe, P. E. AU - Hyder, S. M. PY - 2011 DA - 2011// TI - Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors JO - Breast Cancer Res Treat VL - 125 UR - https://doi.org/10.1007/s10549-010-0851-x DO - 10.1007/s10549-010-0851-x ID - Liang2011 ER - TY - JOUR AU - Dai, B. AU - Roife, D. AU - Kang, Y. AU - Gumin, J. AU - Rios Perez, M. V. AU - Li, X. PY - 2017 DA - 2017// TI - Preclinical evaluation of sequential combination of oncolytic adenovirus Delta-24-RGD and Phosphatidylserine-targeting antibody in pancreatic ductal adenocarcinoma JO - Mol Cancer Ther VL - 16 UR - https://doi.org/10.1158/1535-7163.MCT-16-0526 DO - 10.1158/1535-7163.MCT-16-0526 ID - Dai2017 ER - TY - JOUR AU - Yin, Y. AU - Huang, X. AU - Lynn, K. D. AU - Thorpe, P. E. PY - 2013 DA - 2013// TI - Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation JO - Cancer Immunol Res VL - 1 UR - https://doi.org/10.1158/2326-6066.CIR-13-0073 DO - 10.1158/2326-6066.CIR-13-0073 ID - Yin2013 ER - TY - JOUR AU - Gray, M. J. AU - Gong, J. AU - Hatch, M. M. AU - Nguyen, V. AU - Hughes, C. C. AU - Hutchins, J. T. PY - 2016 DA - 2016// TI - Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers JO - Breast Cancer Res VL - 18 UR - https://doi.org/10.1186/s13058-016-0708-2 DO - 10.1186/s13058-016-0708-2 ID - Gray2016 ER - TY - JOUR AU - Freimark, B. D. AU - Gong, J. AU - Ye, D. AU - Gray, M. J. AU - Nguyen, V. AU - Yin, S. PY - 2016 DA - 2016// TI - Antibody-mediated phosphatidylserine blockade enhances the antitumor responses to CTLA-4 and PD-1 antibodies in melanoma JO - Cancer Immunol Res VL - 4 UR - https://doi.org/10.1158/2326-6066.CIR-15-0250 DO - 10.1158/2326-6066.CIR-15-0250 ID - Freimark2016 ER - TY - JOUR AU - Gerber, D. E. AU - Stopeck, A. T. AU - Wong, L. AU - Rosen, L. S. AU - Thorpe, P. E. AU - Shan, J. S. PY - 2011 DA - 2011// TI - Phase I safety and pharmacokinetic study of Bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-1074 DO - 10.1158/1078-0432.CCR-11-1074 ID - Gerber2011 ER - TY - JOUR AU - Gerber, D. E. AU - Spigel, D. R. AU - Giorgadze, D. AU - Shtivelband, M. AU - Ponomarova, O. V. AU - Shan, J. S. PY - 2016 DA - 2016// TI - Docetaxel combined with Bavituximab in previously treated, advanced nonsquamous non-small-cell lung cancer JO - Clin Lung Cancer VL - 17 UR - https://doi.org/10.1016/j.cllc.2016.02.003 DO - 10.1016/j.cllc.2016.02.003 ID - Gerber2016 ER - TY - STD TI - McDonnell T, Wincup C, Buchholz I, Pericleous C, Giles I, Ripoll V, et al. The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS. Blood Rev. 2020;39:100610. https://doi.org/10.1016/j.blre.2019.100610. ID - ref126 ER - TY - JOUR AU - Altiok, S. AU - Valera, M. M. AU - Kreahling, J. AU - Noyes, D. AU - Razabdouski, T. N. AU - Kallinteris, N. L. PY - 2015 DA - 2015// TI - Activation of CD8+ tumor infiltrating lymphocytes by bavituximab in a 3D ex vivo system of lung cancer patients JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/jco.2015.33.15_suppl.3060 DO - 10.1200/jco.2015.33.15_suppl.3060 ID - Altiok2015 ER - TY - JOUR AU - Kallinteris, N. AU - Horn, L. AU - Tang, M. AU - Guennel, T. AU - Yin, S. AU - Lai, J. PY - 2017 DA - 2017// TI - Abstract CT159: IFN-γ analysis in blood and tissue as a potential prognostic and/or predictive biomarker JO - Cancer Res VL - 77 ID - Kallinteris2017 ER - TY - JOUR AU - Gerber, D. E. AU - Horn, L. AU - Boyer, M. AU - Sanborn, R. AU - Natale, R. AU - Palmero, R. PY - 2018 DA - 2018// TI - Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer JO - Ann Oncol VL - 29 UR - https://doi.org/10.1093/annonc/mdy177 DO - 10.1093/annonc/mdy177 ID - Gerber2018 ER -